Serum AGR2 as a useful biomarker for pituitary adenomas

Mamatemin Tohti(Nanjing General Hospital of Nanjing Military Command), Chiyuan Ma(Tongji University), Abdukeyum Abdujilil(People's Hospital of Xinjiang Uygur Autonomous Region), Junyang Li(Shanghai Children's Medical Center), Chao Tang(North Sichuan Medical University), Parhat Yizim(People's Hospital of Xinjiang Uygur Autonomous Region), Guodao Wen(Nanjing General Hospital of Nanjing Military Command)
Clinical Neurology and Neurosurgery
January 9, 2017
10.1016/j.clineuro.2017.01.004
Cited by 42

Related Papers

Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
|Cell Host & Microbe|2021|140
Risk Factors for Rebleeding of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis
|PLoS ONE|2014|129
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore
|Nature Methods|2024|122
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
|Cancer Immunology Immunotherapy|2018|111
Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway
|PLoS ONE|2016|109